02:24 PM EDT, 07/29/2024 (MT Newswires) -- vTv Therapeutics ( VTVT ) said Friday that the US Food and Drug Administration has placed a clinical hold on its cadisegliatin clinical program for type 1 diabetes.

Shares fell past 22%, with intraday trading volume at over 127,000 compared with a daily average of more than 15,000.

Ventyx Biosciences ( VTYX ) said Monday that the phase 2 trial of its VTX958 candidate drug for people with Crohn's disease failed to meet the primary endpoint.

Shares dropped nearly 22% as intraday trading volume rose to over 3.02 million versus a daily average of about 1.1 million.

Centuri Holdings ( CTRI ) , a Southwest Gas Holdings ( SWX ) spin-off that began trading on the New York Stock Exchange on April 18, reported Q2 adjusted earnings and sales Monday that missed analysts' expectations.

Shares of Centuri ( CTRI ) slid 20% after intraday trading volume climbed to almost 1.89 million compared with the stock's daily average of over 588,000.

Price: 16.50, Change: -4.70, Percent Change: -22.17